LFVN Price / Book | LIFEVANTAGE CORP

Lifevantage Corp Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

Lifevantage Corp price/book ratio for the quarter ending 2026-06-30 was 2.33, a 50.60% decline year-over-year.
Lifevantage Corp price/book ratio for the quarter ending 2026-03-31 was 1.65, a 69.50% decline year-over-year.
Lifevantage Corp price/book ratio for the quarter ending 2025-12-31 was 2.4, a 67.45% decline year-over-year.
Lifevantage Corp price/book ratio for the quarter ending 2025-09-30 was 3.73, a 31.53% decline year-over-year.
Lifevantage Corp price/book ratio for fiscal 2026 was 2.33.
Lifevantage Corp price/book ratio for fiscal 2025 was 2.4, a 67.45% decline from fiscal 2024.
Lifevantage Corp price/book ratio for fiscal 2024 was 7.36, a 160.09% increase from fiscal 2023.
Lifevantage Corp price/book ratio for fiscal 2023 was 2.83, a 90.95% increase from fiscal 2022.

Available history: 2011-06-30 to 2026-06-30
Data captured: 2026-06-30

Historical Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.33	$78.11M	$33.59M
2026-03-31	1.65	$54.85M	$33.34M
2025-12-31	2.4	$79.02M	$32.99M
2025-09-30	3.73	$123.61M	$33.16M
2025-06-30	4.71	$163.07M	$34.64M
2025-03-31	5.39	$183.43M	$34.01M
2024-12-31	7.36	$220M	$29.89M
2024-09-30	5.44	$150.81M	$27.7M
2024-06-30	3.09	$80.31M	$25.99M
2024-03-31	2.87	$76.76M	$26.77M
2023-12-31	2.83	$77.28M	$27.31M
2023-09-30	2.8	$81.96M	$29.29M
2023-06-30	1.58	$54.91M	$34.65M
2023-03-31	1.37	$45.85M	$33.44M
2022-12-31	1.48	$47.27M	$31.9M
2022-09-30	1.48	$47.1M	$31.89M
2022-06-30	1.72	$54.34M	$31.52M
2022-03-31	1.76	$59.87M	$34.03M
2021-12-31	2.33	$81.17M	$34.78M
2021-09-30	2.4	$89.61M	$37.31M
2021-06-30	2.72	$100.03M	$36.81M
2021-03-31	3.67	$130.8M	$35.63M
2020-12-31	3.71	$131.89M	$35.52M
2020-09-30	5.03	$171.85M	$34.14M
2020-06-30	5.82	$193.51M	$33.25M
2020-03-31	5.15	$147.24M	$28.6M
2019-12-31	7.67	$223.11M	$29.1M
2019-09-30	6.49	$192.27M	$29.62M
2019-06-30	6.74	$183.2M	$27.2M
2019-03-31	8.27	$204.75M	$24.75M
2018-12-31	8.95	$188.18M	$21.02M
2018-09-30	6.59	$154.99M	$23.53M
2018-07-01	4.09	$89.65M	$21.94M
2018-06-30	4.08	$89.65M	$21.95M
2018-03-31	2.68	$51.65M	$19.3M
2017-12-31	4.1	$67.64M	$16.51M
2017-09-30	3.81	$60.04M	$15.77M
2017-06-30	4.24	$61.62M	$14.53M
2017-03-31	5.5	$76.43M	$13.9M
2016-12-31	7.89	$114.54M	$14.51M
2016-09-30	9.44	$133M	$14.08M
2016-06-30	17.92	$190.78M	$10.65M
2016-03-31	14.42	$127.47M	$8.84M
2015-12-31	19	$133.2M	$7.01M
2015-09-30	17.32	$79.27M	$4.58M
2015-06-30	28.67	$51.78M	$1.81M
2015-03-31	189.51	$536.33M	$2.83M
2014-12-31	197.8	$899.41M	$4.55M
2014-09-30	111.8	$804.48M	$7.2M
2014-06-30	441.45	$1.03B	$2.33M
2014-03-31	349.8	$953.9M	$2.73M
2013-12-31	-2,189.82	$1.2B	-$548,000.00
2013-09-30	55.9	$1.96B	$35.08M
2013-06-30	55.98	$1.9B	$33.95M
2013-03-31	53.55	$1.87B	$34.86M
2012-12-31	49.77	$1.74B	$35.03M
2012-09-30	79.41	$2.71B	$34.12M
2012-06-30	77.17	$2.18B	$28.28M
2012-03-31	127.59	$2.87B	$22.53M
2011-12-31	107.09	$999.38M	$9.33M
2011-09-30	-64.33	$1.04B	-$16.2M
2011-06-30	-49.85	$1.04B	-$20.81M

Annual Price/Book Ratio

Date	Price/Book Ratio	Market capitalization	Shareholder equity
2026-06-30	2.33	$78.11M	$33.59M
2025-12-31	2.4	$79.02M	$32.99M
2024-12-31	7.36	$220M	$29.89M
2023-12-31	2.83	$77.28M	$27.31M
2022-12-31	1.48	$47.27M	$31.9M
2021-12-31	2.33	$81.17M	$34.78M
2020-12-31	3.71	$131.89M	$35.52M
2019-12-31	7.67	$223.11M	$29.1M
2018-12-31	8.95	$188.18M	$21.02M
2017-12-31	4.1	$67.64M	$16.51M
2016-12-31	7.89	$114.54M	$14.51M
2015-12-31	19	$133.2M	$7.01M
2014-12-31	197.8	$899.41M	$4.55M
2013-12-31	-2,189.82	$1.2B	-$548,000.00
2012-12-31	49.77	$1.74B	$35.03M
2011-12-31	107.09	$999.38M	$9.33M

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Adicet Bio, Inc. (ACET)	United States	$0.078B	-0.81
Valion Bio, Inc. (VBIO)	United States	$0.077B
MAIA Biotechnology, Inc. (MAIA)	United States	$0.077B	-2.30
iBio, Inc. (IBIO)	United States	$0.077B	-2.94
Verrica Pharmaceuticals Inc. (VRCA)	United States	$0.076B	-3.39
OS Therapies Inc (OSTX)	United States	$0.076B	-2.17
Gain Therapeutics, Inc. (GANX)	United States	$0.080B	-4.40
Aldeyra Therapeutics, Inc. (ALDX)	United States	$0.074B	-5.57
Cingulate Inc. (CING)	United States	$0.073B	-2.64
Spero Therapeutics, Inc. (SPRO)	United States	$0.073B	17.41